NCT03788369终止不适用
Evaluation of Effectiveness and Safety of Hybrid Coronary Revascularization, a Non-randomized, Prospective, Open-label Registry in Real-world Practice
Seung-Jung Park1 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2019年4月5日最近更新:
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 发起方
- 入组人数
- 6
- 试验地点
- 1
- 主要终点
- a composite event of death, myocardial infarction, TVR(Target Vessel Revascularization), or stroke.
研究概览
简要总结
This study evaluated the effectiveness and safety of Hybrid Coronary Revascularization in real-world practice.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 20 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age 20 and more
- •Hybrid coronary revascularization due to multivessel coronary artery disease(must include left anterior descending artery)
- •Written consent
排除标准
- •Previous CABG(coronary artery bypass graft)
- •Life expectancy ≤1 year
研究组 & 干预措施
Multivessel coronary artery disease
must include left anterior descending artery
干预措施: Hybrid Coronary Revascularization (Procedure)
结局指标
主要结局
a composite event of death, myocardial infarction, TVR(Target Vessel Revascularization), or stroke.
时间窗: 5 years
Patients who have experienced any one of the following events are considered to have experienced the composite outcome: death, myocardial infarction, TVR(Target Vessel Revascularization), or stroke.
次要结局
- Stent thrombosis(5 years)
- Procedural success(5 days)
- a composite event of cardiac death or myocardial infarction(5 years)
- TVR(Target Vessel Revascularization)(5 years)
- TLR(Target Lesion Revascularization)(5 years)
- All death(5 years)
- Cardiac death(5 years)
- Myocardial infarction(5 years)
- a composite event of all death or myocardial infarction(5 years)
- Cerebrovascular event(5 years)
研究者
Seung-Jung Park
Professor, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Asan Medical Center
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Myocardial Hybrid Revascularization Versus Coronary artERy Bypass GraftING for Complex Triple-vessel DiseaseMultivessel Coronary Artery DiseaseNCT02226900InCor Heart Institute60
已完成
不适用
HCR vs. CABG StudyCoronary Artery DiseaseNCT02892474Emory University75
招募中
不适用
Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventional Drug-eluting Stent-based Strategy in Patients With Long and Diffuse Coronary Artery DiseaseDiffuse Coronary Artery DiseasePercutaneous Coronary Intervention (PCI)Coronary Artery DiseaseNCT06710210University Hospital, Geneva150
终止
不适用
FUNctional eFficacy of Hybrid coronAry REvascularizationCoronary Artery DiseaseNCT04698460Tomsk National Research Medical Center of the Russian Academy of Sciences13
已完成
2 期
Safety and Efficacy Study of Hybrid Revascularization in Multivessel Coronary Artery DiseaseHeart DiseaseMyocardial IschaemiaCoronary DiseaseCoronary Artery DiseaseNCT01035567Silesian Centre for Heart Diseases200